Can a muscle intervention result be generalized to a different population?

Understanding the question

Generalization requires a reasoned comparison between the people studied and the people for whom the claim is being made. Age, diagnosis, disease stage, training history, nutrition, medications and baseline function can affect both benefits and risks. An intervention studied in a specific muscle disease cannot automatically be assumed to improve athletic performance, and a study in trained young adults cannot establish effectiveness for age related functional decline. Differences do not make a result irrelevant, but they introduce indirectness. The evidence summary should explain which features are likely to matter biologically and clinically, then state how much direct evidence exists for the intended population.

What a useful investigation needs to consider

Read actual participant characteristics and eligibility rules rather than relying on broad labels such as adults or muscle weakness. A highly selected sample receiving intensive supervision may differ substantially from people who would encounter an intervention in routine care.

Evaluate subgroup claims carefully. A small apparent difference between age or sex groups can be unstable, especially if many comparisons were made. Prefer prespecified interaction analyses and independent confirmation over separate significance tests or an appealing explanation written after the results were known.

Read the detailed explanation

The companion article explores who muscle research results apply to in more depth, with topic-specific explanations and source material.